Knight Therapeutics | GUD - 营业费用

股票价格

7.50

每天变化

0.05 0.67%

每月一次

1.21%

每年

22.35%

Q2 预测

7.39

金融业

CAD

CAD 1.05B

现金及等价物

CAD 76.45M

CAD 82.22M

CAD 394.84M

CAD 165.26M

CAD 77.91M

CAD 6.21M

CAD 24.45M

698

EPS每股收益

CAD -0.09

股本和储备

CAD 767.27M

CAD 64.72M

债务利息支出

CAD 3.92M

CAD 2.46M

CAD 57.78M

CAD 754.73M

CAD -3.79M

CAD 126.9M

CAD 6.21M

普通股股本

CAD 99.68M

257.34

CAD -1.92M

CAD 133.11M

销售和管理费用

CAD 35.45M

CAD 95.4M

贸易债权人

CAD 125.76M

应收帐款人

CAD 183M

	营业费用	更改		日
Acasti Pharma	USD 62.82M		59.73M	2025-09
Akebia Therapeutics	USD 63.08M		8.26M	2025-12
Alaunos Therapeutics	USD 1.19M		148K	2025-09
Aurora Cannabis	CAD 129.98M		16.05M	2025-12
Avita Medical	AUD 28.02M		1.55M	2025-12
Canopy Growth	CAD 87.2M		6.22M	2025-12
Cronos Group	USD 51.59M		70.5M	2025-12
Dianthus Therapeutics	USD 69.82M		29.14M	2025-12
Ionis Pharmaceuticals	USD 364M		54M	2026-03
IQVIA Holdings	USD 1.69B		4.47B	2025-12
Knight Therapeutics	CAD 126.9M		8.29M	2025-12
Moderna	USD 1.54B		259M	2025-12
Omeros	USD 59.16M		20.13M	2024-06
Organigram Holdings	CAD 83.66M		24.44M	2025-12
Organon & Co	USD 1.29B		384M	2025-12
Revvity	USD 626.22M		25.62M	2025-12
Tectonic Therapeutic	USD 21.52M		374K	2025-12
Tilray	USD 237.52M		17.34M	2025-09
Viatris	USD 3.86B		335.7M	2025-12
Xeris Pharmaceuticals	USD 69.03M		1.38M	2025-12